Researchers at the University of Aberdeen have scanned the first set of patients with their prototype Fast Field Cycling MRI scanner. The new technology has been likened to “100 MRIs in one”. The new scanner can extract more information than a traditional MRI machine by switching the strength of the magnetic field during the scanning procedure. The prototype has been used to image the brains...
Medical devices company, CALCIVIS announces that the FDA has accepted its CALCIVIS imaging system Pre-Market Approval (PMA) Application for substantive review. CALCIVIS are focused on revolutionising the management of tooth decay and enabling preventive dentistry, the application was made for their unique CALCIVIS Imaging System which is a sophisticated medical device and consumable combination designed to transform the assessment and management of dental caries and other dental conditions....
The Medical Visualisation Product Forge took place over the weekend. Product Forge partnered with Toshiba Medical Visualisation Systems Europe and Scottish Health Innovations to host a hackathon that aimed to create innovations that would help to improve clinical pathways and advance precision medicine. The event saw 8 teams work over the weekend to develop their concepts in to digital prototypes with guidance and mentorship from...
A new precision medicine study for prostate cancer is set to be launched today by men’s health charity, Prostate Cancer UK. The study will be co-lead by researchers from the University of Glasgow and will aim to drive tailor made treatments for men based on the genetic make-up of their cancer. By developing this research and moving away from a “one size fits all” approach,...
Edinburgh based medical devices company CALCIVIS have announced the results from their PMA clinical study evaluating their new product, CALCIVIS imaging system. CALCIVIS imaging system is a sophisticated medical device designed to transform the assessment and management of tooth decay and other dental conditions. It involves a unique, proprietary bioluminescence approach combined with a specialised imaging device which allows accurate detection and visualisation of demineralisation....
Capsugel announced that they have expanded clinical trial capabilities as well as increased development and manufacturing capabilities for specialised drug products using liquid-filled hard capsule (LFHC) technology. The expansion at Capsugel’s Edinburgh facility will also include a new isolators for high containment pre-dispensing and compounding, high- and low-shear compounding and holding tanks, an additional high-speed encapsulation machine, a capsule banding unit, and added high-containment capabilities for...